INS and metabolic dysfunction-associated steatotic liver disease: Many psychiatric medications, such as certain antidepressants and antipsychotics, are well documented to influence metabolic health by inducing weight gain, altering lipid profiles, and impairing insulin sensitivity [90], all of which are established risk factors for NAFLD [91].